What results did the meta-analysis by Preiss et al. (2011) find regarding the comparison between high- and moderate-dose statins?
The meta-analysis by Preiss et al. (2011) found that cardiovascular events occurred less often in the high-dose statin group (OR: 0.84, 95% CI: 0.75 0.94, NNT=155), resulting in 6.5 fewer CVD events per 1,000 patient-years treated in the high- dose group over a mean follow-up period of 4.9 years. Of the individual CV events, only non-fatal MI (OR: were statistically different.